5Natalie s,larsen I. Angiogenesis research yields new approaches t o cancer treatment and prognosis.J National Cancer Institute，1993，85∶1029.[ ZK)〗
6Zagzag D, Goldenberg M, Brem S. Angiogenesis and blood brain barrier b reakdownmodulate CT contrast enhancement; An experimental study in a rabbit bra in-tumor model.AJR, 1989，153∶141.
7Terayama N, Terada T. Nakanuma Y. A morphometric and Immunohisto chemi cal study onangiogenesis of human metastatic carcinoma of the liver, Hepatology , 1996，24∶816.
8Bosari S, Delellis RA, Healtley G J, Micro vessel quantitation and pro gnosis ininvasive breast carcinoma. Hum pathol, 1992，23∶755
9Tischer E,Mitchell R,Hartman T,et al.The human gene for vascular endothelial growth factor.Mutiple protein forms are encoded through alternative exon splicing[].Journal of Biological Chemistry.1991
10Ferrara N,Houck K,Jakem an L,et al.M olecular and biologicalproperties of the vascular endothelial grow th factor fam ily ofproteins[].Endocrine Reviews.1992
3Barbareschi M,Gasparini G,Morelli L,et al.Novel methods for the determination of the angiogenic activity of human tumors[J].Breast Cancer Res Treat,1995,36(2):181-192.
4Folberg R,Hendrix MJ,Maniotis AJ.Vasculogenic mimicry and tumor angiogenesis[J].Am J Pathol,2000,156(2):361-381.
5Chang YS,di Tomaso E,McDonald DM,et al.Mosaic blood vessels in tumors:frequency of cancer cells in contact with flowing blood[J].Proc Natl Aead Sci USA,2000,97(26):14608-14613.
6Stephan CC,Brock TA.Vascular endothelial growth factor,a muhifunctional polypeptide[J].P R Health Sci J,1996,15(3):169-178.
7Tabara H,Kohno H,Dhar DK,et al.Concurrent expression of angiogenic growth factors and neovascularization during tumourigenesis in colorectal carcinoma patients[J].Acta Oncol,2001,40(5):622-628.
8O'Reilly MS,Holmgren L,Shing Y,et al.Angiostatin:a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma[J].Cell,1994,79(21):315-328.
9Yang H,Xu Z,Iuvone PM,et al.Angiostatin decreases cell migration and vascular endothelium growth factor (VEGF) to pigment epithelium derived factor(PEDF) RNA ratio in vitro and in a murine ocular melanoma model[J].Mol Vis,2006,22(1 2):51 1-517.
10Chen YH,Wu HL,Li C,et al.Anti-angiogenesis mediated by angiostatin K1-3.K1-4 and K1-4.5.Involvement of p53,FasL,AKT and mRNA deregulation[J].Thromb Haemost,2006,95(4):668-677.
